These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17524696)

  • 1. [Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients].
    Andreu G; Vasse J; Hervé F; Tardivel R; Semana G
    Transfus Clin Biol; 2007 May; 14(1):100-6. PubMed ID: 17524696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet additive solutions: a future perspective.
    van der Meer PF
    Transfus Clin Biol; 2007 Dec; 14(6):522-5. PubMed ID: 18420439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of additive solutions on platelet biochemistry.
    Holme S
    Blood Cells; 1992; 18(3):421-30; discussion 431-4. PubMed ID: 1286196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
    Vassallo RR; Adamson JW; Gottschall JL; Snyder EL; Lee W; Houghton J; Elfath MD
    Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new generation of platelet additive solution for storage at 22 degrees C: development and current experience.
    Ringwald J; Zimmermann R; Eckstein R
    Transfus Med Rev; 2006 Apr; 20(2):158-64. PubMed ID: 16565028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances of studies on platelet additive solutions - review].
    Hu WB; Han Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):721-4. PubMed ID: 18549662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of additive solutions for platelets.
    Alhumaidan H; Sweeney J
    J Clin Apher; 2012; 27(2):93-8. PubMed ID: 22298435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].
    Rebibo D; Simonet M; Hauser L
    Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
    Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
    Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
    van der Meer PF; Pietersz RN; Reesink HW
    Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet storage media.
    Gulliksson H
    Vox Sang; 2014 Oct; 107(3):205-12. PubMed ID: 24976010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).
    Azuma H; Hirayama J; Akino M; Miura R; Kiyama Y; Imai K; Kasai M; Koizumi K; Kakinoki Y; Makiguchi Y; Kubo K; Atsuta Y; Fujihara M; Homma C; Yamamoto S; Kato T; Ikeda H
    Transfusion; 2009 Feb; 49(2):214-8. PubMed ID: 18798806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet storage media.
    Gulliksson H
    Transfus Apher Sci; 2001 Jun; 24(3):241-4. PubMed ID: 11791695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium.
    Gulliksson H; AuBuchon JP; Vesterinen M; Sandgren P; Larsson S; Pickard CA; Herschel I; Roger J; Tracy JE; Langweiler M;
    Vox Sang; 2002 Apr; 82(3):131-6. PubMed ID: 11952987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet additive solution - electrolytes.
    Azuma H; Hirayama J; Akino M; Ikeda H
    Transfus Apher Sci; 2011 Jun; 44(3):277-81. PubMed ID: 21498128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAS or plasma for storage of platelets? A concise review.
    van der Meer PF
    Transfus Med; 2016 Oct; 26(5):339-342. PubMed ID: 27273164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution.
    van Rhenen DJ; Gulliksson H; Cazenave JP; Pamphilon D; Davis K; Flament J; Corash L
    Transfus Med; 2004 Aug; 14(4):289-95. PubMed ID: 15285725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.